Cargando…
Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2000
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300807/ http://dx.doi.org/10.1186/bcr108 |
| _version_ | 1782226363419197440 |
|---|---|
| author | Westman, G |
| author_facet | Westman, G |
| author_sort | Westman, G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3300807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2000 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-33008072012-03-14 Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study Westman, G Breast Cancer Res Meeting Abstract BioMed Central 2000 2000-03-12 /pmc/articles/PMC3300807/ http://dx.doi.org/10.1186/bcr108 Text en Copyright ©2000 Current Science Ltd |
| spellingShingle | Meeting Abstract Westman, G Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| title | Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| title_full | Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| title_fullStr | Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| title_full_unstemmed | Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| title_short | Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| title_sort | herceptin (trastuzumab) in patients who overexpress her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300807/ http://dx.doi.org/10.1186/bcr108 |
| work_keys_str_mv | AT westmang herceptintrastuzumabinpatientswhooverexpressher2andhavefailedmultiplechemotherapyregimensforadvancedbreastcancerapragmaticstudy |